The fact that aminoglycosides are inactivated by a variety of beta-lactam antibiotics under specific conditions both in vitro and in vivo has been well documented (1-10, 12, 13) . It was recently reported that tobramycin and netilmicin, but not amikacin or gentamicin, were significantly inactivated by 25 or 50 ,u.g of sulbactam after 24 h at 37°C (11) . The combination of ampicillin-sulbactam is being used with increasing frequency in the United States and occasionally is used in combination with an aminoglycoside for serious infection. This study evaluated the in vitro inactivation of the four most commonly used aminoglycosides by sulbactam alone and in combination with ampicillin or cefoperazone.
The antibiotics gentamicin, tobramycin, netilmicin, amikacin, piperacillin, ampicillin, cefoperazone, and sulbactam were provided by their respective American manufacturers as standardized powders with certified potency. Solutions of aminoglycosides were prepared in drug-free pooled human serum (C-458, frozen and used as supplied, pH 7.4 + 0.2; Bio-Rad, Anaheim, Calif.). Target aminoglycoside concentrations were 8.0 ,ug/ml for gentamicin, tobramycin, and netilmicin and 24 ,ug/ml for amikacin. Samples of each were incubated at 37°C for 24 h to determine natural decay under the test conditions. Other samples of each solution were incubated under the same conditions with added beta-lactams at the concentrations listed (see Table 2 ). Samples were removed from each incubation mixture after 0, 6, and 24 h and frozen at -20°C until assayed.
The assays for gentamicin, tobramycin, and netilmicin were performed by enzyme-mediated immunoassay (EMIT) by using a COBAS-BIO (Roche Analytical Instruments, Nutley, N.J.) with EMIT reagents (Syva Co., Palo Alto, Calif.). The assay for amikacin was measured by fluorescence polarization immunoassay (TDx) by using a TDx instrument and analysis system (Abbott Laboratories, Abbott Park, Ill.) in accordance with the manufacturer's protocol. Tobramycin levels were also measured by bioassay of several samples. All EMITs and bioassays were done in duplicate, and all TDx assays were done once.
Because of the recognized instability at 37°C, the degradation of ampicillin alone in pooled serum was measured by * Corresponding author.
bioassay over a 24-h period. No loss of activity was measurable for 6 h, but by 24 h a 50% loss was observed.
Quality control specimens at two levels (TheraChem Therapeutic Drug Controls; Fisher Diagnostics, Orangeburg, N.Y.) were analyzed in duplicate on each tray of specimens. The control data are listed in Table 1 . In addition, pooled serum with no drugs and pooled serum containing the beta-lactam drugs without aminoglycosides were also assayed for each of the aminoglycosides with uniformly negative results.
The results of this study are summarized in Table 2 . Under the test conditions used, ampicillin and cefoperazone had no significant effect on any of the four aminoglycosides. The failure of the cephalosporin to inactivate aminoglycosides in serum is consistent with the report of Pfaller et al. (8) . No inactivation was observed by piperacillin at 100 and 200 pLg/ml, but at 400 ,ug/ml, piperacillin reduced the concentrations of gentamicin, netilmicin, and tobramycin to 83, 84, and 73% of their original concentrations after 24 h. Amikacin was unaffected by piperacillin (Table 2) . Thus, at the pharmacologic levels expected when these three beta-lactams are used to treat serious infections, it appears that inactivation of concomitantly administered aminoglycosides should be negligible.
Sulbactam, on the other hand, had significant effects on the aminoglycoside concentrations ( Table 3 ). The only difference in procedure between the two experiments was in the interval of storage at -20°C before the assays were performed. In the original experiment, sera was stored for 3 weeks, and in the repeat experiment they were stored for only 4 days. This suggested that inactivation (8) . Our assays used an incubation temperature of 37TC, whereas Pfaller et al. (8) performed their tests at room temperature. That difference is a likely explanation. for the differences in the reported inactivation rates, since temperature is-known to influence the results (10) . In summary, our data indicate that sulbactam with or without ampicillin or cefoperazone does not significantly inactivate aminoglycosides,in vitro when incubated in serum for 24 h at 37°C, provided that the sulbactam concentration is c25 ,ug/ml. At a concentration of 75 ,ug/ml, sulbactam inactivated tobramycin, and at 225 pg/ml, all four aminoglycosides were-inactivated to some degree. Since sulbactam concentrations greater than 25 ,ug/ml are not usually achieved clinically, in vivo inactivation of aminoglycosides by sulbactam is not likely to be a significant problem.
